Teva Reports Third Quarter 2022 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to Teva Reports Third Quarter 2022 Financial Results

Teva Pharma (TEVA) Misses Q3 EPS by 3c; Lowers Revenue Outlook on FX

November 3, 2022 7:08 AM EDT

Teva Pharma (NYSE: TEVA) reported Q3 EPS of $0.59, $0.03 worse than the analyst estimate of $0.62. Revenue for the quarter came in at $3.6 billion versus the consensus estimate of $3.85 billion.

GUIDANCE:

Teva Pharma sees FY2022 EPS of $2.40-$2.60, versus the consensus of... More